Abstract:It has been claimed that barbiturates uncouple oxidative phosphorylations (Brody & Bain, 1954; Brody, 1955). These authors have demonstrated that during the oxidation of pyruvate by liver and brain mitochondria, phosphate uptake was lowered proportionately more than oxygen uptake. Support for the uncoupling theory was derived from certain similarities between the barbiturates and 2:4dinitrophenol (Brody & Bain, 1954). 'The slopes of the inhibition curves of these compounds are remarkably similar although dinitrophenol is the more potent agent. Both depress fatty acid oxidation and stimulate oxidative rate in a phosphatedeficient system. The addition of excess magnesium ion does not reverse the uncoupling action of either the barbiturate or dinitrophenol' (Brody, 1955). Further, barbiturate hypnosis is potentiated by 2:4-dinitrophenol (Killam, Brody & Bain, 1958). None of these arguments is conclusive evidence for uncoupling, and they ignore the major difference that, in vitro, barbiturates inhibit (Bain, 1952) whereas 2:4-dinitrophenol stimulates respiration (Loomis & Lipmann, 1948; Parker, 1958). This difference is readily demonstrated in vivo, for after administration of barbiturates oxygen consumption (Costa & Bonnycastle, 1955) and body temperature (Birnie & Grayson, 1952; Lessin & Parkes, 1957) fall, whereas 2:4-dinitrophenol causes a rise of both oxygen consumption (Cameron, 1958) and body temperature (Stoner, 1956). Other differences in behaviour in isolated systems have also been demonstrated (Johnson & Quastel, 1953; Jalling, Low, Ernster & Lindberg, 1957; Messer, 1958). Although the supporting evidence for the uncoupling theory is not conclusive, Brody & Bain (1954) have nevertheless demonstrated a lowering of the phosphorylation quotient (P/O ratio). Respiration, with pyruvate as substrate, of the liver mitochondria used in this paper can be inhibited 50% without any decrease of the P/O ratio (Aldridge, 1957). With such preparations we have re-examined the effect ofoxyand thio-barbiturates upon oxidative phosphorylation. Moreover, by dissociating the process of oxidation from that of oxidative phosphorylation by the intervention of 2:4-dinitrophenol (Loomis & Lipmann, 1948; Parker, 1958), we have studied the effects of barbiturates upon these processes separately. A preliminary report of these results has already appeared (Aldridge & Parker, 1958).

Synthesis of Boron-Containing Nucleoside Analogs

Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine

Experience with a Three-Point Method for Planning Rhinoplasty

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

Rubella in the distant past as a possible cause of congenital malformations.

The HemoCue WBC DIFF system could be used for leucocyte and neutrophil counts but not for full differential counts

Recent developments in the medicinal chemistry of single boron atom-containing compounds

Sweet Boron: Boron-Containing Sugar Derivatives as Potential Agents for Boron Neutron Capture Therapy

Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy

[The abdominal aorta in ultrasonic tomography].

Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy

Boron Chemistry for Medical Applications

Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy

Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds

Boronated thymidine analogues for boron neutron capture therapy

Interfractional reproducibility of lung tumor location using various methods of respiratory motion mitigation.

Boron Salicylate Ester Compounds as Boron Therapeutics. Their Synthesis, Structural Characterizations and Anticancer Effects against MDA-MB-231

Boron in cancer therapeutics: An overview

Barbiturates and oxidative phosphorylation.

The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry

Design and Synthesis of Bicyclo[4.3.0]nonene Nucleoside Analogues